Zoledronic Acid Injection, Solution
NDC Package 43598-255-52
Package Information
Zoledronic Acid injection is indicated for the treatment of hypercalcemia of malignancy defined as an albuminĀ-corrected calcium (cCa) of greater than or equal to 12 mg/dL [3 mmol/L] using the formula: cCa in mg/dL=Ca in mg/dL + 0.8 (4 g/dL - patient albumin [g/dL]). This formulation utilizes a injection, solution delivery system. Marketed by Dr. Reddy's Laboratories Inc, this product is identified by NDC 43598-255 and is authorized under FDA application ANDA204344.
Identification & Billing
- RxCUI: 1114085 - zoledronic acid 4 MG in 100 ML Injection
- RxCUI: 1114085 - 100 ML zoledronic acid 0.04 MG/ML Injection
- RxCUI: 1114085 - zoledronic acid 4 MG per 100 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43598 - Dr. Reddy's Laboratories Inc
- 43598-255 - Zoledronic Acid
- 43598-255-52 - 1 BOTTLE in 1 CARTON / 100 mL in 1 BOTTLE
- 43598-255 - Zoledronic Acid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43598-255-52 identifies a specific commercial package of 1 bottle in 1 carton / 100 ml in 1 bottle of Zoledronic Acid, a human prescription drug labeled by Dr. Reddy's Laboratories Inc. This injection, solution is formulated for intravenous use and contains zoledronic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dr. Reddy's Laboratories Inc on January 15, 2019. The current certification is valid through December 31, 2026.
How is this Dr. Reddy's Laboratories Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43598025552. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.